MHC matching fails to prevent long-term rejection of iPSC-derived neurons in non-human primates

Cell therapy products (CTP) derived from pluripotent stem cells (iPSCs) may constitute a renewable, specifically differentiated source of cells to potentially cure patients with neurodegenerative disorders. However, the immunogenicity of CTP remains a major issue for therapeutic approaches based on...

Descripción completa

Detalles Bibliográficos
Autores principales: Aron Badin, Romina, Bugi, Aurore, Williams, Susannah, Vadori, Marta, Michael, Marie, Jan, Caroline, Nassi, Alberto, Lecourtois, Sophie, Blancher, Antoine, Cozzi, Emanuele, Hantraye, Philippe, Perrier, Anselme L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761126/
https://www.ncbi.nlm.nih.gov/pubmed/31554807
http://dx.doi.org/10.1038/s41467-019-12324-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761126/
https://www.ncbi.nlm.nih.gov/pubmed/31554807
http://dx.doi.org/10.1038/s41467-019-12324-0

Ejemplares similares